Latest & greatest articles for Prostate Cancer Staging

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Prostate Cancer Staging or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Prostate Cancer Staging and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Prostate Cancer Staging

21. Comparison of laparoscopic and minilaparotomy pelvic lymphadenectomy for prostate cancer staging in a community practice

, Cattolica E V. Comparison of laparoscopic and minilaparotomy pelvic lymphadenectomy for prostate cancer staging in a community practice. Urology 1997; 49(1): 60-63 PubMedID DOI Indexing Status Subject indexing assigned by NLM MeSH Aged; Cost-Benefit Analysis; Humans; Laparoscopy; Laparotomy; Lymph Node Excision /economics /methods; Lymphatic Metastasis; Male; Neoplasm Staging; Prostatic Neoplasms /pathology /surgery AccessionNumber 21997000200 Date bibliographic record published 28/02/1999 Date abstract (...) Comparison of laparoscopic and minilaparotomy pelvic lymphadenectomy for prostate cancer staging in a community practice Comparison of laparoscopic and minilaparotomy pelvic lymphadenectomy for prostate cancer staging in a community practice Comparison of laparoscopic and minilaparotomy pelvic lymphadenectomy for prostate cancer staging in a community practice St Lezin M, Cherrie R, Cattolica E V Record Status This is a critical abstract of an economic evaluation that meets the criteria

1997 NHS Economic Evaluation Database.

22. Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer

at least 1.2 years. Authors' conclusions The results show that endorectal magnetic resonance imaging techniques are more cost-effective than conventional magnetic resonance imaging for the staging of prostate cancer and that strict criteria should be used for the diagnosis of extracapsular disease. The authors indicated that, whilst they have shown the relative superiority of one magnetic resonance imaging method over another, they have not shown that either magnetic resonance imaging technique (...) Fellowship. Bibliographic details Langlotz C P, Schnall M D, Malkowicz S B, Schwartz J S. Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer. Academic Radiology 1996; 3(Supplement 1): S24-S27 PubMedID Indexing Status Subject indexing assigned by NLM MeSH Cost-Benefit Analysis; Humans; Magnetic Resonance Imaging /economics; Male; Models, Economic; Neoplasm Staging /economics; Prostate /pathology; Prostatic Neoplasms /economics /mortality /pathology; Quality

1996 NHS Economic Evaluation Database.

23. Chest radiography in patients with early stage prostatic carcinoma: effect on treatment planning and cost analysis

Chest radiography in patients with early stage prostatic carcinoma: effect on treatment planning and cost analysis Chest radiography in patients with early stage prostatic carcinoma: effect on treatment planning and cost analysis Chest radiography in patients with early stage prostatic carcinoma: effect on treatment planning and cost analysis Forman H P, Fox L A, Glazer H S, McClennan B L, Anderson D C, Sage S S Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Preoperative routine chest radiography in patients with early stage prostatic carcinoma. Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. Study population Asymptomatic patients with prostatic carcinoma detected in a specific antigen

1994 NHS Economic Evaluation Database.

24. Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. (Abstract)

Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group. The independent prognostic factors affecting survival were assessed in 240 men undergoing treatment for metastatic prostate cancer as part of a randomized clinical trial comparing the gonadotropin releasing hormone analogue Zoladex (goserelin acetate implant) with castration. In a multivariate analysis, the most highly significant predictors were the presence or absence of bone pain (...) less than 6.9 nmol/L, significant differences in survival were observed for patients with serum testosterone levels of 10.4 to 13.9, 13.9 to 17.3, and over 17.3 nmol/L. These results have important implications for the design and analysis of future clinical trials of hormone therapy and for counseling patients regarding the short-term prognosis of their disease.

1991 JAMA Controlled trial quality: uncertain